Oxidation of PKGIα mediates an endogenous adaptation to pulmonary hypertension

Significance This study demonstrates that oxidation of protein kinase G Iα (PKGIα) to its disulfide-activated state occurs in pulmonary arteries during chronic hypoxia, and that this is a protective event that limits progression of pulmonary hypertension by at least two mechanisms. Firstly, it induces pulmonary vasodilation that counters and offsets maladaptive vasoconstriction during chronic hypoxia, and, secondly, disulfide PKGIα is protective by preventing maladaptive growth and fibrosis signaling. Consistent with oxidation of PKGIα being protective, administration of polysulfides to mice during hypoxia, which increased the abundance of the disulfide form of the kinase, was therapeutic and limited disease progression. Chronic hypoxia causes pulmonary hypertension (PH), vascular remodeling, right ventricular (RV) hypertrophy, and cardiac failure. Protein kinase G Iα (PKGIα) is susceptible to oxidation, forming an interprotein disulfide homodimer associated with kinase targeting involved in vasodilation. Here we report increased disulfide PKGIα in pulmonary arteries from mice with hypoxic PH or lungs from patients with pulmonary arterial hypertension. This oxidation is likely caused by oxidants derived from NADPH oxidase-4, superoxide dismutase 3, and cystathionine γ-lyase, enzymes that were concomitantly increased in these samples. Indeed, products that may arise from these enzymes, including hydrogen peroxide, glutathione disulfide, and protein-bound persulfides, were increased in the plasma of hypoxic mice. Furthermore, low-molecular-weight hydropersulfides, which can serve as “superreductants” were attenuated in hypoxic tissues, consistent with systemic oxidative stress and the oxidation of PKGIα observed. Inhibiting cystathionine γ-lyase resulted in decreased hypoxia-induced disulfide PKGIα and more severe PH phenotype in wild-type mice, but not in Cys42Ser PKGIα knock-in (KI) mice that are resistant to oxidation. In addition, KI mice also developed potentiated PH during hypoxia alone. Thus, oxidation of PKGIα is an adaptive mechanism that limits PH, a concept further supported by polysulfide treatment abrogating hypoxia-induced RV hypertrophy in wild-type, but not in the KI, mice. Unbiased transcriptomic analysis of hypoxic lungs before structural remodeling identified up-regulation of endothelial-to-mesenchymal transition pathways in the KI compared with wild-type mice. Thus, disulfide PKGIα is an intrinsic adaptive mechanism that attenuates PH progression not only by promoting vasodilation but also by limiting maladaptive growth and fibrosis signaling.

[1]  Paul G. Williams,et al.  Haemodynamic definitions and updated clinical classification of pulmonary hypertension , 2019, European Respiratory Journal.

[2]  P. Siques,et al.  Reactive Oxygen Species and Pulmonary Vasculature During Hypobaric Hypoxia , 2018, Front. Physiol..

[3]  L. Ignarro,et al.  Biological hydropersulfides and related polysulfides – a new concept and perspective in redox biology , 2018, FEBS letters.

[4]  S. Uhlig,et al.  The effects of hydroxyethyl starch and gelatine on pulmonary cytokine production and oedema formation , 2018, Scientific Reports.

[5]  E. Vighi,et al.  New dimeric cGMP analogues reduce proliferation in three colon cancer cell lines. , 2017, European journal of medicinal chemistry.

[6]  K. D. Straub,et al.  Metabolism of hydrogen sulfide (H2S) and Production of Reactive Sulfur Species (RSS) by superoxide dismutase , 2017, Redox biology.

[7]  Akira Nishimura,et al.  Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics , 2017, Nature Communications.

[8]  T. Okazaki,et al.  Production of reactive persulfide species in chronic obstructive pulmonary disease , 2017, Thorax.

[9]  Y. Nishijima,et al.  Contribution of KV1.5 Channel to Hydrogen Peroxide–Induced Human Arteriolar Dilation and Its Modulation by Coronary Artery Disease , 2016, Circulation research.

[10]  A. Bonev,et al.  Pressure-induced oxidative activation of PKG enables vasoregulation by Ca2+ sparks and BK channels , 2016, Science Signaling.

[11]  W. Seeger,et al.  NADPH Oxidase 4 is Not Involved in Hypoxia-Induced Pulmonary Hypertension , 2016, Pulmonary circulation.

[12]  A. Shah,et al.  Transcriptional Regulation of Cystathionine-γ-Lyase in Endothelial Cells by NADPH Oxidase 4-Dependent Signaling , 2015, The Journal of Biological Chemistry.

[13]  E. Skrzydlewska,et al.  Sildenafil reduces signs of oxidative stress in pulmonary arterial hypertension: Evaluation by fatty acid composition, level of hydroxynonenal and heart rate variability , 2015, Redox biology.

[14]  H. Schmidt,et al.  Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement. , 2015, Antioxidants & redox signaling.

[15]  A. Shah,et al.  Deficient angiogenesis in redox-dead Cys17Ser PKARIα knock-in mice , 2015, Nature Communications.

[16]  P. Eaton,et al.  Redox regulation of cGMP-dependent protein kinase Iα in the cardiovascular system , 2015, Front. Pharmacol..

[17]  M. Humbert,et al.  Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension , 2015, Circulation.

[18]  A. Shah Parsing the role of NADPH oxidase enzymes and reactive oxygen species in heart failure. , 2015, Circulation.

[19]  Jenna Scotcher,et al.  Protein Kinase G I&agr; Oxidation Paradoxically Underlies Blood Pressure Lowering by the Reductant Hydrogen Sulfide , 2014, Hypertension.

[20]  D. Harrison,et al.  Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[21]  M. Wolin,et al.  Exposure of mice to chronic hypoxia attenuates pulmonary arterial contractile responses to acute hypoxia by increases in extracellular hydrogen peroxide. , 2014, American journal of physiology. Regulatory, integrative and comparative physiology.

[22]  R. Macallister,et al.  Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension , 2014, Circulation.

[23]  M. Yeager,et al.  Animal Models of Pulmonary Hypertension: Matching Disease Mechanisms to Etiology of the Human Disease , 2014, Journal of pulmonary & respiratory medicine.

[24]  Yunchao Su,et al.  NADPH Oxidase 4 Is Expressed in Pulmonary Artery Adventitia and Contributes to Hypertensive Vascular Remodeling , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[25]  J. Lambeth,et al.  Nox4: A Hydrogen Peroxide-Generating Oxygen Sensor , 2014, Biochemistry.

[26]  P. Eaton,et al.  Biochemical methods for monitoring protein thiol redox states in biological systems , 2014, Redox biology.

[27]  M. Suematsu,et al.  Reactive cysteine persulfides and S-polythiolation regulate oxidative stress and redox signaling , 2014, Proceedings of the National Academy of Sciences.

[28]  D. Becher,et al.  Polysulfides link H2S to protein thiol oxidation. , 2013, Antioxidants & redox signaling.

[29]  P. Eaton,et al.  PSS171 – Redox-Dead Protein Kinase a RIα knock-in Mouse Is Not Hypertensive But Has Increased Vascular Reactivity to Oxidants , 2013 .

[30]  Keng Jin Lee,et al.  Isolation of pulmonary artery smooth muscle cells from neonatal mice. , 2013, Journal of visualized experiments : JoVE.

[31]  T. Murphy,et al.  Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells. , 2013, Free radical biology & medicine.

[32]  M. Humbert,et al.  Riociguat for the treatment of pulmonary arterial hypertension. , 2013, The New England journal of medicine.

[33]  René M. Botnar,et al.  Protein kinase G oxidation is a major cause of injury during sepsis , 2013, Proceedings of the National Academy of Sciences.

[34]  Yuichiro J Suzuki,et al.  Reactive oxygen species and antioxidants in pulmonary hypertension. , 2013, Antioxidants & redox signaling.

[35]  M. Gladwin,et al.  Antioxidant therapy for the treatment of pulmonary hypertension. , 2013, Antioxidants & redox signaling.

[36]  R. Feil,et al.  H₂O₂ lowers the cytosolic Ca²⁺ concentration via activation of cGMP-dependent protein kinase Iα. , 2012, Free radical biology & medicine.

[37]  A. Shah,et al.  Redox Signaling in Cardiac Physiology and Pathology , 2012, Circulation research.

[38]  B. Kang,et al.  The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation. , 2012, American journal of respiratory cell and molecular biology.

[39]  P. Eaton,et al.  Nitroglycerin Fails to Lower Blood Pressure in Redox-Dead Cys42Ser PKG1&agr; Knock-In Mouse , 2012, Circulation.

[40]  F. Hofmann,et al.  Protein kinase G-I deficiency induces pulmonary hypertension through Rho A/Rho kinase activation. , 2012, The American journal of pathology.

[41]  M. Gladwin,et al.  Reactive oxygen and nitrogen species in pulmonary hypertension. , 2012, Free radical biology & medicine.

[42]  M. Silva,et al.  Antioxidants for Preventing Preeclampsia: A Systematic Review , 2012, TheScientificWorldJournal.

[43]  W. Seeger,et al.  Hypoxia induces Kv channel current inhibition by increased NADPH oxidase-derived reactive oxygen species. , 2012, Free radical biology & medicine.

[44]  J. Cui,et al.  cGMP-dependent protein kinase Iα transfection inhibits hypoxia-induced migration, phenotype modulation and annexins A1 expression in human pulmonary artery smooth muscle cells. , 2012, Biochemical and biophysical research communications.

[45]  M. Wolin,et al.  Roles for redox mechanisms controlling protein kinase G in pulmonary and coronary artery responses to hypoxia. , 2011, American journal of physiology. Heart and circulatory physiology.

[46]  P. Eaton,et al.  Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension , 2011, Nature Medicine.

[47]  Xinli Hu,et al.  Exacerbated Pulmonary Arterial Hypertension and Right Ventricular Hypertrophy in Animals With Loss of Function of Extracellular Superoxide Dismutase , 2011, Hypertension.

[48]  H. Ghofrani,et al.  Mechanisms of disease: pulmonary arterial hypertension , 2011, Nature Reviews Cardiology.

[49]  R. Banerjee,et al.  Structural basis for substrate activation and regulation by cystathionine beta-synthase (CBS) domains in cystathionine β-synthase , 2010, Proceedings of the National Academy of Sciences.

[50]  Gene Kim,et al.  Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial Hypertension: A Basis for Excessive Cell Proliferation and a New Therapeutic Target , 2010, Circulation.

[51]  A. Petry,et al.  The NADPH Oxidase Subunit NOX4 Is a New Target Gene of the Hypoxia-inducible Factor-1 , 2010, Molecular biology of the cell.

[52]  A. Firth,et al.  Idiopathic pulmonary arterial hypertension , 2010, Disease Models & Mechanisms.

[53]  Joseph R. Burgoyne,et al.  Oxidant Sensing by Protein Kinases A and G Enables Integration of Cell Redox State with Phosphoregulation , 2010, Sensors.

[54]  E. Halpern,et al.  Noninvasive Assessment of Murine Pulmonary Arterial Pressure: Validation and Application to Models of Pulmonary Hypertension , 2010, Circulation. Cardiovascular imaging.

[55]  A. Malik,et al.  Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. , 2009, The Journal of clinical investigation.

[56]  Ping Wu,et al.  NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[57]  D. Robertson Faculty Opinions recommendation of H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. , 2008 .

[58]  S. Snyder,et al.  H2S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of Cystathionine γ-Lyase , 2008, Science.

[59]  E. Nozik-Grayck,et al.  Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[60]  D. Browning Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer , 2008, Expert opinion on therapeutic targets.

[61]  Y. Sasaguri,et al.  Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats. , 2008, American journal of respiratory and critical care medicine.

[62]  J. P. Brennan,et al.  Cysteine Redox Sensor in PKGIa Enables Oxidant-Induced Activation , 2007, Science.

[63]  L. Shimoda,et al.  Ca2+ signaling in hypoxic pulmonary vasoconstriction: effects of myosin light chain and Rho kinase antagonists. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[64]  W. Seeger,et al.  Hypoxia-Dependent Regulation of Nonphagocytic NADPH Oxidase Subunit NOX4 in the Pulmonary Vasculature , 2007, Circulation research.

[65]  T. Kawahara,et al.  Regulation of Nox and Duox enzymatic activity and expression. , 2007, Free radical biology & medicine.

[66]  R. Wait,et al.  Oxidant-induced Activation of Type I Protein Kinase A Is Mediated by RI Subunit Interprotein Disulfide Bond Formation* , 2006, Journal of Biological Chemistry.

[67]  P. Aaronson,et al.  Hypoxic pulmonary vasoconstriction: mechanisms and controversies , 2006, The Journal of physiology.

[68]  Yahong Chen,et al.  Endogenous hydrogen sulfide in patients with COPD. , 2005, Chest.

[69]  K. Krause Tissue distribution and putative physiological function of NOX family NADPH oxidases. , 2004, Japanese journal of infectious diseases.

[70]  N. Voelkel,et al.  Oxidative stress in severe pulmonary hypertension. , 2004, American journal of respiratory and critical care medicine.

[71]  B. Walker,et al.  Pulmonary PKG-1 is upregulated following chronic hypoxia. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[72]  N. Morrell,et al.  Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension , 2001, Circulation.

[73]  T. Lincoln,et al.  Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha. , 1999, Science.

[74]  C. Packer,et al.  Hypoxia-induced pulmonary arterial contraction appears to be dependent on myosin light chain phosphorylation. , 1996, The American journal of physiology.

[75]  E. Nozik-Grayck,et al.  Redox Regulation of the Superoxide Dismutases SOD3 and SOD2 in the Pulmonary Circulation. , 2017, Advances in experimental medicine and biology.

[76]  S. Archer Acquired Mitochondrial Abnormalities, Including Epigenetic Inhibition of Superoxide Dismutase 2, in Pulmonary Hypertension and Cancer: Therapeutic Implications. , 2016, Advances in experimental medicine and biology.

[77]  H. Ghofrani,et al.  Recent Advances in Pulmonary Hypertension , 2015 .

[78]  D. Browning,et al.  cGMP-dependent protein kinases as potential targets for colon cancer prevention and treatment. , 2010, Future medicinal chemistry.

[79]  L. Gluud,et al.  Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. , 2008, The Cochrane database of systematic reviews.

[80]  E. Nozik-Grayck,et al.  Role of reactive oxygen species in chronic hypoxia-induced pulmonary hypertension and vascular remodeling. , 2007, Advances in experimental medicine and biology.